DB
HAE icon

Danske Bank’s Haemonetics HAE Stock Holding History

Danske Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$16K – 1339
2025
Q4 		$16K Sell
200
-13,453
-99% -$904K ﹤0.01% 1243
2025
Q3 		$665K Sell
13,653
-5,200
-28% -$322K ﹤0.01% 742
2025
Q2 		$1.41M Buy
18,853
+11,853
+169% +$785K ﹤0.01% 667
2025
Q1 		$445K Buy
+7,000
New +$476K ﹤0.01% 879
2024
Q4 		– Sell
-4,472
Closed -$359K – 1505
2024
Q3 		$359K Sell
4,472
-10,820
-71% -$874K ﹤0.01% 924
2024
Q2 		$1.27M Sell
15,292
-5,053
-25% -$445K ﹤0.01% 724
2024
Q1 		$1.74M Buy
+20,345
New +$1.6M 0.01% 726

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Danske Bank's HAE Position: Q1 2026 in Review

Danske Bank sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 200 shares — an estimated $16K sold.

Danske Bank first reported a position in HAE in Q1 2024 and held it in 7 quarters. The position peaked at $1.74M in Q1 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Danske Bank reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 200 Haemonetics shares in Q1 2026, an estimated $16K.
  • Danske Bank first reported a position in Haemonetics in Q1 2024 and held it in 7 quarters.
  • Danske Bank's Haemonetics position peaked at $1.74M in Q1 2024.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.